// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Prevalence and Factors Associated with Pre-term Delivery at Ad-Din Women’s Medical College and Hospital in Bangladesh

Jhuma Biswas - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Accuracy of Clinical Methods and Sonographic Method of Foetal Weight Estimation at Term

Omotayo O. Akinro - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Importance of Knowing Gestational Age and Methods for Assessment – Perspectives from Rural Sub-Saharan Africa

Angela Etyang - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Premaquick versus Transvaginal Ultrasonographically Measured Cervical Length for Pre-induction Cervical Assessment at Term: A Randomized Clinical Trial

Chigozie G. Okafor - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Prostaglandin

A Scoping Review of Maternal Antibiotic Prophylaxis in Low- And Middle-Income Countries: Comparison to Who Recommendations for Prevention and Treatment of Maternal Peripartum Infection

Imogen Jury - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Preterm premature rupture of the membranes

N/A

Adapting Maternal and Perinatal Death Surveillance and Response Systems during a Public Health Crisis

Subha Sri Balakrishnan - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Incidence and Management of Third- and Fourth-Degree Perineal Tear in a University Teaching Hospital

Maryam Jamshaid - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Acceptability of a Mobile Clinical Decision Support System (SMARThealth Pregnancy) for Community Health Workers in Rural India to Screen Refer & Counsel Pregnant Women at High Risk of Future Cardiometabolic Disorders

Shobhana Nagraj - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Cardiometabolic syndrome

N/A

Vaginal Delivery of Both Twins in Diamniotic Gestations. Intrapartum Predictors and Risks: Insights from a 4yr Experience

Tolu O. Adedipe - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Can Forceps Be Eliminated in Vaginal Breech by Using Upright Positions and the “Crowning Touch” Manoeuvre?

Betty-Anne Daviss - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Maternal near Miss in Namibia: Findings of a Nationwide Population-Based Surveillance Study

Steffie Heemelaar - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Keilland Forceps. Useful Instrument or Dangerous One? Retrospective Study

Christos Spyroulis - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Shoulder dystocia

N/A

Exploring the Shared Decision-Making Process of Caesarean Sections at the Korle-Bu Teaching Hospital Ghana: A Mixed Methods Study

Kwaku Asah-Opoku - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Systematic Review of Brachial Plexus Injuries During Caesarean Section

Shireen Jaufuraully - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Shoulder dystocia

N/A

Induction of Labour and Nulliparity: A Nation-Wide Clinical Practice Pilot Evaluation

Ingvil Krarup Sørbye - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

PREVALENCE SEVERITY AND ASSOCIATED FACTORS IN WOMEN IN EAST ASIA WITH MODERATE-TO-SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE

Qi Yu - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

PREGNANCY RATES AND PERINATAL OUTCOMES FOLLOWING LAPAROSCOPIC AND OPEN MYOMECTOMIES

Nana Opare - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

THE IMPACT OF OBESITY ON CONCEPTION SUCCESS RATE FOLLOWING CLOMIPHENE CITRATE USE FOR ANOVULATORY INFERTILITY OF OVARIAN ORIGIN

Maryam Jamshaid - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Infertility

clomiphene

OHVIRA SYNDROME: A CASE REPORT AND REVIEW OF THE LITERATURE

Hannah Mistry - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ADDRESSING THE BARRIERS TO SAFE ABORTION AND POST-ABORTION CARE THROUGH ADVOCACY IN RWANDA

Merel Krediet - International Federation of Gynecology and Obstetrics (FIGO) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved